User profiles for Neil Davie

Neil Davie

South Westphalia University of Applied Sciences
Verified email at fh-swf.de
Cited by 158

Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage

…, JA Brunetti, DL Burke, TC Carpenter, NJ Davie… - The American journal of …, 2006 - Elsevier
Vascular remodeling in chronic hypoxic pulmonary hypertension includes marked
fibroproliferative changes in the pulmonary artery (PA) adventitia. Although resident PA fibroblasts …

ETA and ETB Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells

N Davie, SJ Haleen, PD Upton, JM Polak… - American journal of …, 2002 - atsjournals.org
We determined the distribution of ET A and ET B receptors in pulmonary arteries from
pulmonary hypertensive patients and control subjects, using in vitro autoradiography, and …

Role of the adventitia in pulmonary vascular remodeling

KR Stenmark, N Davie, M Frid… - …, 2006 - journals.physiology.org
An increasing volume of experimental data indicates that the adventitial fibroblast, in both
the pulmonary and systemic circulations, is a critical regulator of vascular wall function in …

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)

…, C Wang, MR Wilkins, A Fritsch, N Davie… - European …, 2015 - Eur Respiratory Soc
Riociguat is a soluble guanylate cyclase stimulator approved for the treatment of inoperable
and persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH). In the …

Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells

NJ Davie, JT Crossno Jr, MG Frid… - … of Physiology-Lung …, 2004 - journals.physiology.org
Information is rapidly emerging regarding the important role of the arterial vasa vasorum in
a variety of systemic vascular diseases. In addition, increasing evidence suggests that …

Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)

…, A Fritsch, F Menezes, N Davie… - European …, 2015 - Eur Respiratory Soc
Riociguat is a soluble, guanylate cyclase stimulator, approved for pulmonary arterial
hypertension. In the 12-week PATENT-1 study, riociguat was well tolerated and improved several …

Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells

J Wharton, N Davie, PD Upton, MH Yacoub, JM Polak… - Circulation, 2000 - Am Heart Assoc
Background—Prostacyclin has proved to be a beneficial treatment for patients with severe
pulmonary hypertension. We postulated that the response may reflect, at least in part, …

Hypoxia, leukocytes, and the pulmonary circulation

KR Stenmark, NJ Davie, JT Reeves… - Journal of applied …, 2005 - journals.physiology.org
Data are rapidly accumulating in support of the idea that circulating monocytes and/or
mononuclear fibrocytes are recruited to the pulmonary circulation of chronically hypoxic animals …

Mobile-Assisted Language Learning: Student Attitudes to Using Smartphones to Learn English Vocabulary.

N Davie, T Hilber - International Association for Development of the …, 2015 - ERIC
This project examines mobile-assisted language learning (MALL) and in particular the
attitudes of undergraduate engineering students at the South Westphalia University of Applied …

Nomophobia: Is Smartphone Addiction a Genuine Risk for Mobile Learning?.

N Davie, T Hilber - International association for development of the …, 2017 - ERIC
Repeated surveys have shown that all students at our university have smartphones and use
them regularly both at home and in the university. Excessive regular use of anything, …